Novartis Prize
The Novartis Prize denotes various awards:
- the prize for therapy-relevant pharmacological research, awarded by the Novartis Foundation and the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT); it is endowed with around 10,000 euros and is awarded every two years at the annual meeting of the DGPT.
- the Novartis "Young Endocrinology" Prize of the German Society for Endocrinology (DGE) for the promotion of clinical and experimental endocrinology . It has been awarded since 2004 and is endowed with 10,000 euros.
Winner of the Novartis Prize of the DGPT
| year | Award winners | Quote |
|---|---|---|
| 1992/1993 | Rudi Busse , Markus Hecker , Wolfgang Linz , Gabriele Wiemer | "Deepening the understanding of the complex effects of ACE inhibition" |
| 1994/1995 | Thomas Eschenhagen | "Molecular mechanism for changes in inhibitory G-proteins in heart failure and cardiac arrhythmias" |
| Albrecht Wendel , Gisa Tiegs , Johannes Barsig , Thomas Hartung Tier | "Animal experimental findings of G-CSF in sepsis prophylaxis" | |
| 1996/1997 | Holger Bang | "Role of Cyclophilins in the Effect of Potent Immunosuppressants in Important Infectious Diseases" |
| Markus Meyer , Thomas Flights | "Physiological effects and pharmacological properties of urodilatin and its therapeutic use in acute kidney failure and bronchial asthma" | |
| 1998/1999 | Ralph Lucius , Stefan Gallinat | "Neurothrophic effect of angiotensin II and its promoting effect on axonal regeneration after lesion of the optic nerve through the mediation of the angiotensin receptor subtype AT2" |
| 2000/2001 | Georg Nickenig | "Importance of AT1 receptors for the understanding of the pathophysiology and the therapy of atherosclerosis" |
| 2002/2003 | Michael Schön , Wolf-Henning Boehncke | "Efomycin M: specific inhibition of selectin-mediated leukocyte adhesion for the treatment of inflammatory diseases" |
| 2004/2005 | Günter Schwarz , Jochen Reiss | "Rescue of lethal molybdenum cofactor deficiency by a biosynthetic precursor from Escherichia coli" |
| 2006/2007 | Frank Lyko | "The development of DNA methyltransferase inhibitors as epigenetic cancer therapeutics" |
| 2008/2009 | Irmgard Tegeder | "GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence" |
| 2010/2011 | Jan Schwab | "Resolution of Inflammation: Concept and Mechanisms. Lipid mediator resolution agonists: a strategy to treat Inflammation & Implications for CNS lesions; (en) " |
| 2012/2013 | Christoph Welsch | "Peptidomimetic Escape Mechanisms Arise via Genetic Diversity in the Ligand-Binding Site of the Hepatitis C Virus NS3 / 4A Serine Protease" |
| 2014/2015 | Nina Wettschureck , Markus Schwaninger | "Hydroxycarboxylic acid receptor 2 mediates dimethy fumarate's protective effect in EAE" |
| 2016/2017 | Rohini Kuner | "New therapy-relevant mediators of neuropathic pain based on the interaction between sensory neurons and T cells." |
| Lars Zender (together with other scientists) | "A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer." | |
| 2018/2019 | not forgiven | - |
Winner of the Novartis “Young Endocrinology” Prize
- 2009 Constanze Hantel (LMU Munich Clinic)
- 2017 Sara Jung (LMU Clinic, Munich)
Web links
Individual evidence
- ↑ German Society for Endocrinology honors outstanding hormone researchers. In: German Society for Endocrinology. March 5, 2009, accessed March 18, 2020 .